Gahart's 2021 Intravenous Medications: A Handbook for Nurses and Health Professionals [37 ed.] 9780323757386, 0323757383

Table of contents :
Ifc
How to use
HOW TO USE THIS BOOK
STEP 1
STEP 2
That’s it!
Develop the “look it up” habit.
Front matter
Gahart’s 2021INTRAVENOUS MEDICATIONS
Copyright
Dedication
Reviewers
NURSING AND PHARMACOLOGY CONSULTANTS
Preface
Contents
Evolve website information,
General Dilution Charts,
How to Use This Book,
Preface,
Format and Content of Intravenous Medications,
Key to Abbreviations,
Important IV Therapy Facts,
Resources,
IV Drugs,
Appendix A
Appendix B
Appendix C
Appendix D
Appendix E
Index,
Solution Compatibility Chart,
Selected Agents Not Included in the Book,
Format and content of
USUAL DOSE:
Pretreatment:
Premedication:
Dose:
PEDIATRIC DOSE:
INFANT AND/OR NEONATAL DOSE:
DOSE ADJUSTMENTS:
DILUTION:
Filters:
Storage:
COMPATIBILITIES
RATE OF ADMINISTRATION:
ACTIONS:
INDICATIONS AND USES:
Limitation of Use:
CONTRAINDICATIONS:
PRECAUTIONS:
Monitor:
Patient Education:
Maternal/Child:
Elderly:
DRUG/LAB INTERACTIONS:
SIDE EFFECTS:
Post-Marketing:
ANTIDOTE:
Key to abbreviations
Important IV therapy facts
USUAL DOSE
DILUTION
INCOMPATIBILITIES
TECHNIQUES
RATE OF ADMINISTRATION
PATIENT EDUCATION
SIDE EFFECTS
Resources
PUBLICATIONS
WEBSITE RESOURCES
Generic drugs: A
A
ABATACEPT
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ABCIXIMAB
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ACETAMINOPHEN
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ACETAZOLAMIDE SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ACETYLCYSTEINE INJECTION
USUAL DOSE (ADULT AND PEDIATRIC)
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ACYCLOVIR
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ADENOSINE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ADO-TRASTUZUMAB EMTANSINE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ALBUMIN (HUMAN)
USUAL DOSE
PEDIATRIC DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ALDESLEUKIN
USUAL DOSE (International units [IU])
DOSE ADJUSTMENTS
DILUTION (International units [IU])
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ALEMTUZUMAB
USUAL DOSE
Campath
Pretreatment:
Premedication:
Dose escalation:
Maintenance dose:
Anti-infective prophylaxis:
Lemtrada
Pretreatment:
Premedication: Corticosteroids:
Herpes prophylaxis:
Lemtrada:
First treatment course:
Second treatment course:
Subsequent treatment courses:
DOSE ADJUSTMENTS
Campath and Lemtrada
Campath
DILUTION
Campath
Lemtrada
Filters:
Storage: Campath:
Lemtrada:
Campath and Lemtrada:
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
Campath
Lemtrada
CONTRAINDICATIONS
Campath
Lemtrada
PRECAUTIONS
Campath and Lemtrada
Campath
Lemtrada
Monitor: Campath:
Lemtrada:
Patient Education: Campath and Lemtrada:
Campath:
Lemtrada:
Maternal/Child: Campath and Lemtrada:
Campath:
Lemtrada:
Elderly: Campath:
Lemtrada:
DRUG/LAB INTERACTIONS
Campath and Lemtrada
Campath
Lemtrada
SIDE EFFECTS
Campath
Lemtrada
Post-Marketing: Campath:
Lemtrada:
ANTIDOTE
Campath and Lemtrada
Campath
Lemtrada
ALLOPURINOL SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ALPROSTADIL
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ALTEPLASE
USUAL DOSE
Acute Myocardial Infarction
Accelerated infusion:
3-hour infusion:
Acute Ischemic Stroke
Pulmonary Embolism
Central Venous Access Device (CVAD) Occlusions, Cathflo Activase
Patient weight 30 kg or greater:
Patient weight less than 30 kg:
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
AMIKACIN SULFATE
USUAL DOSE
PEDIATRIC DOSE
NEWBORN DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
AMINOCAPROIC ACID
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
AMINOPHYLLINE
USUAL DOSE
Bronchodilation in Acute Asthma or Bronchospasm
Adults, children, infants, and neonates who have not received a theophylline preparation in the previous 24 hours:
Adults, children, infants, and neonates who have received a theophylline preparation in the previous 24 hours: A serum the ...
Maintenance infusion:
Reverse Adenosine-Mediated Effects of Dipyridamole in Adults (Unlabeled)
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
AMIODARONE HYDROCHLORIDE
USUAL DOSE
Treatment and Prophylaxis of Ventricular Tachycardia (VT) and Ventricular Fibrillation (VF)
Rapid loading infusion:
Slow loading infusion:
Maintenance infusion:
Treatment of Breakthrough Ventricular Fibrillation (VF) or Hemodynamically Unstable Ventricular Tachycardia (VT)
Cardiac Arrest (unlabeled)
Supraventricular Arrhythmias (unlabeled)
Intravenous to Oral Transition
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
AMPHOTERICIN B **The Black Box Warning applies only to the generic formulation. ■ AMPHOTERICIN B LIPID-BASED PRODUCTS
USUAL DOSE
Abelcet (Amphotericin B Lipid Complex Injection)
Adults and pediatric patients:
AmBisome (Amphotericin B Liposome for Injection)
Adults, children, and infants over 1 month of age:
Empirical therapy in febrile, neutropenic patients:
Systemic fungal infections (e.g., Aspergillus, Candida, Cryptococcus):
Treatment of cryptococcal meningitis in HIV-infected patients:
Visceral leishmaniasis in immunocompetent patients:
Visceral leishmaniasis in immunocompromised patients:
Generic (Conventional Amphotericin B)
Adults and pediatric patients:
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
All Formulations
Abelcet
AmBisome/Generic
Generic (Conventional)
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
AMPICILLIN SODIUM
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
AMPICILLIN SODIUM AND SULBACTAM SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ANGIOTENSIN II INJECTION
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ANIDULAFUNGIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ANTIHEMOPHILIC FACTOR (HUMAN ■ RECOMBINANT ■ RECOMBINANT [Fc FUSION PROTEIN] ■ RECOMBINANT [PEGYLATED] ...
USUAL DOSE (International units [IU])
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ANTIHEMOPHILIC FACTOR ■ VON WILLEBRAND FACTOR COMPLEX (HUMAN)
USUAL DOSE (International units [IU])
Alphanate
Treatment of hemophilia A (adults):
Humate-P
Treatment of hemophilia A (adults):
Treatment of von Willebrand Disease (vWD) (adults and pediatric patients):
Prevention of excessive bleeding during and after surgery in vWD:
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
Alphanate
Humate-P
CONTRAINDICATIONS
Alphanate:
Humate-P:
PRECAUTIONS
Alphanate and Humate-P:
Monitor:
Patient Education:
Maternal/Child:
Elderly:
DRUG/LAB INTERACTIONS
SIDE EFFECTS
Alphanate and Humate-P:
Post-Marketing:
ANTIDOTE
ANTI-INHIBITOR COAGULANT COMPLEX
USUAL DOSE
Feiba
Joint hemorrhage:
Mucous membrane bleeding:
Serious soft tissue hemorrhage:
Other severe hemorrhage (e.g., CNS bleeding):
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ANTITHROMBIN III (HUMAN)
USUAL DOSE (International units [IU])
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ANTITHROMBIN RECOMBINANT
USUAL DOSE (International units [IU])
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ANTI-THYMOCYTE GLOBULIN (RABBIT)
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
APREPITANT
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ARGATROBAN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ARSENIC TRIOXIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ATEZOLIZUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ATROPINE SULFATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
AVELUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
AZACITIDINE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
AZITHROMYCIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
AZTREONAM
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: B
B
BASILIXIMAB
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BELATACEPT
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BELIMUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BELINOSTAT
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BENDAMUSTINE HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BEVACIZUMAB ■ BEVACIZUMAB-awwbaaPlease see p. x for more information on biosimilars. ■ BEVACIZUMAB-bvzra
USUAL DOSE
Bevacizumab products
Metastatic colorectal cancer (mCRC):
First-line non-squamous, non–small-cell lung cancer (NSCLC):
Recurrent glioblastoma:
Metastatic renal cell carcinoma (mRCC):
Persistent, recurrent, or metastatic cervical cancer:
Bevacizumab (Avastin)
Stage III or IV epithelial ovarian, fallopian tube, or primary peritoneal cancer after initial surgical resection:
Platinum-resistant recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer:
Platinum-sensitive recurrent epithelial ovarian, fallopian tube, or primary peritoneal cancer:
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
Bevacizumab products
Bevacizumab (Avastin)
Limitation of use:
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BEZLOTOXUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BIVALIRUDIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BLEOMYCIN SULFATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BLINATUMOMAB
USUAL DOSE
Relapsed or refractory B-cell precursor (acute) lymphoblastic leukemia (ALL)
Premedication: Adults:
Pediatric patients:
Blinatumomab dosage:
Treatment of Minimal Residual Disease (MRD)–Positive B-cell Precursor (ALL)
Premedication: Adults:
Pediatric patients:
Blinatumomab dosage:
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BORTEZOMIB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BRENTUXIMAB VEDOTIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BRIVARACETAM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BUMETANIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BUPRENORPHINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BUSULFAN
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
BUTORPHANOL TARTRATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: C
C
C1 ESTERASE INHIBITOR (HUMAN OR RECOMBINANT)
USUAL DOSE (International units [IU])
Berinert
Treatment of an acute attack:
Cinryze
Routine prophylaxis dosing:
Ruconest
Treatment of an acute attack:
DILUTION
Berinert
Cinryze
Ruconest
Filters: Berinert:
Cinryze and Ruconest:
Storage: All Formulations:
Berinert:
Cinryze:
Ruconest:
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CABAZITAXEL
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CAFFEINE CITRATE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CALASPARGASE PEGOL-mknl
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CALCITRIOL
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CALCIUM CHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CALCIUM GLUCONATE
USUAL DOSE
PEDIATRIC AND NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CANGRELOR
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CARBAMAZEPINE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CARBOPLATIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CARFILZOMIB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CARMUSTINE (BCNU)
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CASPOFUNGIN ACETATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFAZOLIN SODIUM
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFEPIME HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFOTAXIME SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFOTETAN DISODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFOXITIN SODIUM
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE (unlabeled)
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFTAROLINE FOSAMIL
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFTAZIDIME
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFTAZIDIME/AVIBACTAM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFTOLOZANE/TAZOBACTAM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFTRIAXONE SODIUM
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFUROXIME SODIUM
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEMIPLIMAB-rwlc
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CETUXIMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CHLORPROMAZINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CIDOFOVIR INJECTION
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CIPROFLOXACIN
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CISATRACURIUM BESYLATE
USUAL DOSE
Adjunct to Propofol/N2O/O2 Anesthesia for Adults (IV Bolus)
Initial dose:
Maintenance dose:
Continuous infusion:
Support of Intubated, Mechanically Ventilated Adult ICU Patients
PEDIATRIC DOSE
Adjunct to Halothane or Opioid Anesthesia for Pediatric Patients 1 Month to 23 Months of Age
Adjunct to Halothane or Opioid Anesthesia for Pediatric Patients 2 to 12 Years of Age
Initial dose:
Maintenance dose:
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CISPLATIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CLADRIBINE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CLEVIDIPINE BUTYRATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CLINDAMYCIN PHOSPHATE
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CLOFARABINE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
COAGULATION FACTOR VIIa (RECOMBINANT) RTS
USUAL DOSE
Hemophilia A or B Patients with Inhibitors
Bleeding episodes:
Surgical intervention:
Congenital Factor VII Deficiency Patients
Bleeding episodes and surgical intervention:
Acquired Hemophilia
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
COAGULATION FACTOR X (HUMAN)
USUAL DOSE (INTERNATIONAL UNITS [IU])
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
COAGULATION FACTOR Xa (RECOMBINANT), INACTIVATED-zhzo
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
COAGULATION FACTOR XIII A-SUBUNIT (RECOMBINANT)
USUAL DOSE (International units [IU])
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CONIVAPTAN HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
COPANLISIB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
COSYNTROPIN
USUAL DOSE
PEDIATRIC DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CYCLOPHOSPHAMIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CYCLOSPORINE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CYTARABINE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CYTOMEGALOVIRUS IMMUNE GLOBULIN INTRAVENOUS (HUMAN) **This drug is on the Black Box Warning list; however, a BBW is not pr ...
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: D
D
DACARBAZINE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DALBAVANCIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DANTROLENE SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DAPTOMYCIN
USUAL DOSE
All Formulations
Complicated skin and skin structure infections (cSSSI):
Staphylococcus aureus bloodstream infections (bacteremia), including those with right-sided endocarditis:
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
Cubicin RF
Adults:
Pediatric patients 7 to 17 years of age (30-minute infusion):
Pediatric patients 1 to 6 years of age (60-minute infusion):
Filters:
Storage: Cubicin and generics:
Cubicin RF:
All formulations:
COMPATIBILITY
RATE OF ADMINISTRATION
All Formulations
Injection: Adults:
Infusion: Adults:
Pediatric patients 7 to 17 years of age:
Pediatric patients 1 to 6 years of age:
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DARATUMUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DARBEPOETIN ALFA
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DAUNORUBICIN AND CYTARABINE LIPOSOME FOR INJECTION
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DAUNORUBICIN HYDROCHLORIDE  ■ DAUNORUBICIN CITRATE LIPOSOMAL INJECTION
USUAL DOSE
All Daunorubicins
Pretreatment:
Conventional Daunorubicin
Adult acute nonlymphocytic leukemia:
Adult acute lymphocytic leukemia:
DaunoXome (Liposomal Injection)
Advanced, HIV-associated Kaposi’s sarcoma:
PEDIATRIC DOSE
Conventional Daunorubicin
Acute lymphocytic leukemia in pediatric patients 2 years of age and older:
Acute lymphocytic leukemia in infants and children under 2 years of age or less than 0.5 M2 body surface:
DaunoXome:
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
Conventional Daunorubicin
DaunoXome
RATE OF ADMINISTRATION
Conventional Daunorubicin
IV injection:
IV infusion:
DaunoXome
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DECITABINE FOR INJECTION
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DELAFLOXACIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DESMOPRESSIN ACETATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DEXAMETHASONE SODIUM PHOSPHATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DEXMEDETOMIDINE HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DEXRAZOXANE
USUAL DOSE
Totect
Day 1 and Day 2:
Day 3:
Zinecard
DOSE ADJUSTMENTS
Totect and Zinecard
Zinecard
DILUTION
Totect
Preparation of Totect, using SWFI and LR:
Preparation of Totect, using 0.167 M sodium lactate injection and NS:
Zinecard
Storage: Totect and Zinecard:
COMPATIBILITY
RATE OF ADMINISTRATION
Totect
Zinecard
ACTIONS
Dexrazoxane
Totect
Zinecard
INDICATIONS AND USES
Totect
Zinecard
CONTRAINDICATIONS
Totect
Zinecard
PRECAUTIONS
Totect and Zinecard
Totect
Zinecard
Monitor: Totect and Zinecard:
Totect:
Zinecard:
Patient Education:
Maternal/Child:
Elderly:
DRUG/LAB INTERACTIONS
Totect and Zinecard
Totect
Zinecard
SIDE EFFECTS
ANTIDOTE
DEXTRAN HIGH MOLECULAR WEIGHT
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DEXTRAN LOW MOLECULAR WEIGHT
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DEXTROSE
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DIAZEPAM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DICLOFENAC SODIUM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DIGOXIN
USUAL DOSE
Loading dosing regimen in adults and pediatric patients:
Maintenance dosing in adults and pediatric patients over 10 years of age:
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DIGOXIN IMMUNE FAB (OVINE)
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DIHYDROERGOTAMINE MESYLATE
USUAL DOSE
PEDIATRIC DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DILTIAZEM HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DINUTUXIMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DIPHENHYDRAMINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DIPYRIDAMOLE
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DOBUTAMINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DOCETAXEL
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DOPAMINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DORIPENEM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DOXERCALCIFEROL
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DOXORUBICIN HYDROCHLORIDE  ■ DOXORUBICIN HYDROCHLORIDE LIPOSOMAL INJECTION
USUAL DOSE
Conventional Doxorubicin
Breast cancer with lymph node involvement after resection:
Adjuvant treatment of operable node-positive breast cancer:
Doxil (Liposomal Doxorubicin)
AIDS-related Kaposi’s sarcoma:
Ovarian cancer:
Multiple myeloma:
Bortezomib:
Doxil:
Breast cancer (unlabeled):
PEDIATRIC DOSE
DOSE ADJUSTMENTS
Conventional Doxorubicins:
Breast cancer with lymph node involvement after resection:
Doxil:
DILUTION
COMPATIBILITY
Conventional Doxorubicin
Doxil
RATE OF ADMINISTRATION
Conventional Doxorubicin
IV injection:
Continuous infusion:
Doxil
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
All Doxorubicins:
Conventional Doxorubicin:
Doxil:
DOXYCYCLINE HYCLATE
USUAL DOSE
Adults and Pediatric Patients Weighing 45 kg or More
Primary and secondary syphilis:
Acute pelvic inflammatory disease:
Treatment of inhalational anthrax (postexposure):
PEDIATRIC DOSE
All Doses are For Pediatric Patients Weighing Less Than 45 kg
Treatment of inhalational anthrax (postexposure):
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DROPERIDOL
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
DURVALUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: E
E
ECULIZUMAB
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
EDARAVONE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ELOTUZUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
EMAPALUMAB-lzsg
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ENALAPRILAT
USUAL DOSE
PEDIATRIC DOSE (UNLABELED)
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
EPINEPHRINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
EPIRUBICIN HYDROCHLORIDE
USUAL DOSE
Ellence
Pretreatment:
Premedication:
Epirubicin:
Pharmorubicin PFS
Metastatic breast cancer: Single agent:
Early-stage breast cancer (Stage II-IIIA):
Small-cell lung cancer: Single agent:
Non–small-cell lung cancer: Single agent:
Non-Hodgkin lymphoma: Single agent:
Hodgkin disease: Combination therapy:
Ovarian cancer: Single agent:
Locally unresectable or metastatic gastric cancer: Single agent:
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
EPOETIN ALFA , ■ EPOETIN ALFA-epbxa
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
EPOPROSTENOL SODIUM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
EPTIFIBATIDE
USUAL DOSE
Acute Coronary Syndrome
Eptifibatide:
Aspirin:
Heparin: Medical management:
Patients undergoing PCI:
Percutaneous Coronary Intervention (PCI)
Eptifibatide:
Aspirin:
Heparin:
For Both Indications
DOSE ADJUSTMENTS
Acute Coronary Syndrome
PCI
All Diagnoses
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ERAVACYCLINE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ERIBULIN MESYLATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ERTAPENEM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ERYTHROMYCIN LACTOBIONATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ESMOLOL HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ESOMEPRAZOLE SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ETELCALCETIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ETEPLIRSEN
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ETOMIDATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ETOPOSIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
Nonphosphate Products (e.g., VePesid)
Phosphate Products (e.g., Etopophos)
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: F
F
FACTOR IX (HUMAN) ■ FACTOR IX COMPLEX (HUMAN)
USUAL DOSE (International units [IU])
All Formulations
Minor hemorrhage:
Major trauma or surgery:
Dental extraction:
Prophylaxis:
Factor IX Complex
Reversal of coumarin effect:
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FACTOR IX (RECOMBINANT)
USUAL DOSE (International units [IU])
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FACTOR XIII CONCENTRATE (HUMAN)
USUAL DOSE (International units [IU])
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FAMOTIDINE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FAT EMULSION, INTRAVENOUS
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FENOLDOPAM MESYLATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FENTANYL CITRATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FERRIC CARBOXYMALTOSE INJECTION
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FERUMOXYTOL
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FIBRINOGEN CONCENTRATE (HUMAN)
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FILGRASTIM ■ FILGRASTIM-aafiaaPlease see p. x for more information on biosimilars. ■ FILGRASTIM-sndza
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FISH OIL TRIGLYCERIDES INJECTABLE EMULSION
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FLUCONAZOLE
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FLUDARABINE PHOSPHATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FLUMAZENIL
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FLUOROURACIL
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FOSAPREPITANT DIMEGLUMINE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FOSCARNET SODIUM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FOSNETUPITANT AND PALONOSETRON
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FOSPHENYTOIN SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FUROSEMIDE
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: G
G
GANCICLOVIR SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
GEMCITABINE HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
GEMTUZUMAB OZOGAMICIN
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
GENTAMICIN SULFATE
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
GLUCAGON
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
GLUCARPIDASE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
GLYCOPYRROLATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
GOLIMUMAB
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
GRANISETRON HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: H
H
HEMIN
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
HEPARIN SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
HEPATITIS B IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
USUAL DOSE (International units [IU])
DOSE ADJUSTMENTS (International units [IU])
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
HYDRALAZINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
HYDROCORTISONE SODIUM SUCCINATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
HYDROMORPHONE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
HYDROXOCOBALAMIN
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: I
I
IBALIZUMAB-uiyk
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IBANDRONATE SODIUM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IBUPROFEN
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IBUPROFEN LYSINE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IBUTILIDE FUMARATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IDARUBICIN HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IDARUCIZUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IFOSFAMIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IMIPENEM-CILASTATIN
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IMMUNE GLOBULIN INTRAVENOUS
USUAL DOSE
Primary Immunodeficiency (PID) Diseases
Bivigam and Gammuplex:
Carimune NF:
Flebogamma, Gammagard Liquid, Gammagard S/D, Gammaked, Gamunex-C, Octagam 5%, and Panzyga:
Privigen:
Idiopathic Thrombocytopenic Purpura (ITP)
Carimune NF:
Flebogamma 10%:
Gammagard S/D:
Gammaked and Gamunex-C:
Gammaplex, Octagam 10%, Privigen, and Panzyga: Chronic ITP:
B-Cell Chronic Lymphocytic Leukemia (CLL)
Gammagard S/D:
Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Gamunex-C and Gammaked: Loading dose:
Privigen: Loading dose:
Multifocal Motor Neuropathy (MMN)
Gammagard Liquid:
PEDIATRIC DOSE
Kawasaki Syndrome
Gammagard S/D:
Other Indications
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
INDOMETHACIN SODIUM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
INFLIXIMAB  ■ INFLIXIMAB-dyybaaPlease see p. x for more information on biosimilars. ■ INFLIXIMAB-abdaa ■ IN ...
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
INOTUZUMAB OZOGAMICIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
INSULIN HUMAN INJECTION (REGULAR) ■ INSULIN ASPART ■ INSULIN GLULISINE ■ INSULIN LISPRO
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IPILIMUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IRINOTECAN HYDROCHLORIDE ■ IRINOTECAN LIPOSOME INJECTION
USUAL DOSE
Conventional Irinotecan
Premedication: Antiemetics:
First-line treatment of colorectal cancer:
Treatment of colorectal cancer after failure of treatment with fluorouracil: Irinotecan:
Onivyde (Liposomal Irinotecan)
Premedication:
Metastatic adenocarcinoma of the pancreas:
DOSE ADJUSTMENTS
Conventional Irinotecan
Combination therapy:
Single-agent therapy:
ONIVYDE
DILUTION
COMPATIBILITY
Conventional Irinotecan
ONIVYDE
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IRON DEXTRAN INJECTION
USUAL DOSE
PEDIATRIC DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IRON SUCROSE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ISAVUCONAZONIUM SULFATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ISOPROTERENOL HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IXABEPILONE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: K
K
KETOROLAC TROMETHAMINE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: L
L
LABETALOL HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LACOSAMIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LETERMOVIR
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LEUCOVORIN CALCIUM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LEVETIRACETAM INJECTION
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LEVOFLOXACIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LEVOLEUCOVORIN
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LEVOTHYROXINE SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LIDOCAINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LINEZOLID
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LORAZEPAM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LYMPHOCYTE IMMUNE GLOBULIN
USUAL DOSE
PEDIATRIC DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: M
M
MAGNESIUM SULFATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MANNITOL
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MELPHALAN HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MEROPENEM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MEROPENEM AND VABORBACTAM FOR INJECTION
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MESNA
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
METHADONE HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
METHOTREXATE SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
METHYLERGONOVINE MALEATE
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
METHYLPREDNISOLONE SODIUM SUCCINATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
METOCLOPRAMIDE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
METOPROLOL TARTRATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
METRONIDAZOLE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MICAFUNGIN SODIUM
USUAL DOSE
PEDIATRIC DOSE
Dosage for pediatric patients under 4 months of age: Treatment of candidemia, acute disseminated candidiasis, Candida per ...
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
Limitations of Use:
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MIDAZOLAM HYDROCHLORIDE
USUAL DOSE
Sedation, Anxiolysis (Antianxiety), and/or Amnesia for Short Diagnostic, Endoscopic, and Therapeutic Procedures
Healthy adults under 60 years of age:
Patients over 60 years of age or debilitated or chronically ill patients:
Induction of Anesthesia Before Administration of Other Anesthetic Agents and/or Maintenance of Anesthesia as a Component o ...
Unpremedicated patients under 55 years of age:
Unpremedicated patients over 55 years of age (ASA I or II):
Unpremedicated debilitated patients or those with severe systemic disease (ASA III or IV):
Patients premedicated with sedatives or narcotics under 55 years of age:
Patients premedicated with sedatives or narcotics over 55 years of age (Good risk [ASA I & II]):
Patients premedicated with sedatives or narcotics who are debilitated or those with severe systemic disease (ASA III or IV):
Sedation for Anesthesia or Treatment in a Critical Care Setting for Intubated and Mechanically Ventilated Patients
Continuous infusion:
For maintenance of sedation:
Refractory Status Epilepticus (Unlabeled)
PEDIATRIC DOSE
Sedation, Anxiolysis (Antianxiety), and/or Amnesia Before and During Procedures or Before Anesthesia
Nonintubated infants under 6 months of age:
Pediatric patients 6 months to 5 years of age:
Pediatric patients 6 to 12 years of age:
Pediatric patients 12 to 16 years of age:
Sedation, Anxiolysis, Amnesia
Intubated pediatric patients in critical care settings:
Sedation of Intubated Neonates in Critical Care Settings
Neonates under 32 weeks:
Neonates 32 weeks or older:
Refractory Status Epilepticus (Unlabeled)
Pediatric patients 2 months of age or older:
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MILRINONE LACTATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MITOMYCIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MITOXANTRONE HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MOGAMULIZUMAB-kpkc
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MORPHINE SULFATE
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MOXETUMOMAB PASUDOTOX-tdfk
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MOXIFLOXACIN HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MYCOPHENOLATE MOFETIL HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: N
N
NAFCILLIN SODIUM
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
NALBUPHINE HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
NALOXONE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
NATALIZUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
NECITUMUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
NELARABINE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
NEOSTIGMINE METHYLSULFATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
NICARDIPINE HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
NITROGLYCERIN IV
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
NITROPRUSSIDE SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
NIVOLUMAB
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
NOREPINEPHRINE BITARTRATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: O
O
OBINUTUZUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
OCRELIZUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
OCTREOTIDE ACETATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
OFATUMUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
OLARATUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
OMADACYCLINE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ONDANSETRON HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ORITAVANCIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
OXALIPLATIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
OXYTOCIN INJECTION
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: P
P
PACLITAXEL ■ PACLITAXEL PROTEIN-BOUND PARTICLES FOR INJECTABLE SUSPENSION (ALBUMIN-BOUND)
USUAL DOSE
Conventional Paclitaxel
Premedication:
Ovarian cancer in previously untreated patients:
Ovarian cancer in patients previously treated with chemotherapy:
Adjuvant treatment of node-positive breast cancer:
Breast cancer in patients previously treated with chemotherapy:
First-line treatment of non–small-cell lung cancer:
AIDS-related Kaposi’s sarcoma:
Abraxane
Premedication:
Metastatic breast cancer (MBC):
Non–small-cell lung cancer (NSCLC):
Adenocarcinoma of the pancreas:
DOSE ADJUSTMENTS
Conventional Paclitaxel
Abraxane
DILUTION
Conventional Paclitaxel
Abraxane
Filters: Conventional paclitaxel:
Storage: Conventional paclitaxel:
COMPATIBILITY
Conventional Paclitaxel
Abraxane
RATE OF ADMINISTRATION
Conventional Paclitaxel
Abraxane
ACTIONS
All Formulations
Conventional Paclitaxel
Abraxane
INDICATIONS AND USES
Conventional Paclitaxel
Abraxane
Unlabeled uses: Conventional paclitaxel:
CONTRAINDICATIONS
Conventional Paclitaxel
Abraxane
PRECAUTIONS
All Formulations
Conventional Paclitaxel
Abraxane
Monitor: All Formulations:
Conventional Paclitaxel:
Abraxane:
Patient Education: All Formulations:
Maternal/Child: All Formulations:
Conventional Paclitaxel:
Elderly: All Formulations:
Conventional Paclitaxel:
Abraxane:
DRUG/LAB INTERACTIONS
All Formulations
Conventional Paclitaxel
Abraxane
SIDE EFFECTS
Conventional Paclitaxel
Post-Marketing:
Abraxane
Post-Marketing:
ANTIDOTE
PALIFERMIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PALONOSETRON
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PAMIDRONATE DISODIUM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PANITUMUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PANTOPRAZOLE SODIUM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PAPAVERINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PARICALCITOL
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PATISIRAN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
MATERNAL/CHILD:
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PEGASPARGASE ■ ASPARAGINASE Erwinia chrysanthemi
USUAL DOSE (International units [IU])
DOSE ADJUSTMENTS
DILUTION (International units [IU])
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PEGLOTICASE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PEMBROLIZUMAB
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PEMETREXED
USUAL DOSE
Premedication Required
Folic acid supplementation:
Vitamin B12 supplementation:
Corticosteroid:
Prehydration:
Pemetrexed
Malignant pleural mesothelioma:
Nonsquamous non–small-cell lung cancer (NSCLC): Initial treatment of locally advanced or metastatic NSCLC:
Maintenance treatment of locally advanced or metastatic NSCLC:
Treatment of recurrent/metastatic disease:
Initial treatment of metastatic NSCLC:
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PENICILLIN G AQUEOUS
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PENTAMIDINE ISETHIONATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PENTOBARBITAL SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PENTOSTATIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PERAMIVIR
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PERTUZUMAB
USUAL DOSE
Metastatic Breast Cancer (MBC)
Initial doses: Pertuzumab:
Trastuzumab:
Subsequent doses:
Pertuzumab:
Trastuzumab:
Docetaxel:
Neoadjuvant Treatment of Breast Cancer
Adjuvant Treatment of Breast Cancer
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PHENOBARBITAL SODIUM
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PHENYLEPHRINE HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PHENYTOIN SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PHOSPHATE
USUAL DOSE
INFANT DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
All Formulations
Potassium Phosphate
Sodium Phosphate
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PHYSOSTIGMINE SALICYLATE
USUAL DOSE
PEDIATRIC DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PHYTONADIONE
USUAL DOSE
PEDIATRIC DOSE
NEWBORN DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PIPERACILLIN SODIUM AND TAZOBACTAM SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PLAZOMICIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PORFIMER SODIUM
USUAL DOSE
Esophageal and Endobronchial Cancer
Esophageal cancer:
Endobronchial non–small-cell lung cancer:
High-Grade Dysplasia (HGD in Barrett’s Esophagus [BE])
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
POSACONAZOLE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
POTASSIUM ACETATE AND POTASSIUM CHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PRALATREXATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PROCAINAMIDE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PROCHLORPERAZINE EDISYLATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PROMETHAZINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PROPOFOL INJECTION
USUAL DOSE
Induction of Anesthesia
Healthy adults under 55 years of age:
Adults over 55 years of age, debilitated, or ASA III or IV risk patients:
Cardiac anesthesia:
Neurosurgical patients:
Maintenance of Anesthesia
Adults under 55 years:
Adults over 55 years of age, debilitated, or ASA III or IV risk patients:
Cardiac anesthesia:
Neurosurgical patients:
Initiation of Monitored Anesthesia Care (MAC) Sedation
Healthy adults under 55 years of age:
Adults over 55 years of age, debilitated, or ASA III or IV risk patients:
Maintenance of MAC Sedation
Healthy adults under 55 years:
Adults over 55 years, debilitated, or ASA III or IV risk patients:
Sedation of Intubated, Mechanically Ventilated ICU Patients
Maintenance of Sedation in Mechanically Ventilated or Respiratory-Controlled ICU Patients
Relief of Pruritus Associated with Use of Spinal Opiates or Cholestasis (Unlabeled)
Management of Refractory Status Epilepticus (Unlabeled)
PEDIATRIC DOSE
Induction of Anesthesia in Healthy Pediatric Patients 3 to 16 Years of Age
Maintenance of Anesthesia in Healthy Pediatric Patients From 2 Months to 16 Years of Age
Pediatric patients 2 months of age and older:
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PROPRANOLOL HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE (UNLABELED)
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PROTAMINE SULFATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PROTEIN AMINO ACIDS, DEXTROSE, FAT EMULSION, AND ELECTROLYTES
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
PROTHROMBIN COMPLEX CONCENTRATE (HUMAN)
USUAL DOSE (International Units [IU])
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: Q
Q
QUINUPRISTIN/DALFOPRISTIN
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: R
R
RAMUCIRUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
RANITIDINE
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
RASBURICASE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
RAVULIZUMAB-cwvz
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
RESLIZUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
RETEPLASE RECOMBINANT
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Rho(D) IMMUNE GLOBULIN INTRAVENOUS (HUMAN)
USUAL DOSE (International units [IU])
PEDIATRIC DOSE
DOSE ADJUSTMENTS (International units [IU])
DILUTION (International units [IU])
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS (International units [IU])
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
RIFAMPIN
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
RITUXIMAB  ■ RITUXIMAB-abbsaaPlease see p. x for more information on biosimilars.  ■ RITUXIMAB-pvvra
USUAL DOSE
Rituximab Products
Relapsed or refractory, low-grade or follicular, CD20-positive, B-cell non-Hodgkin lymphoma (NHL): Single agent: Initial t ...
Previously untreated follicular, CD20-positive, B-cell NHL:
Nonprogressing, low-grade, CD20-positive, B-cell NHL (after first-line CVP chemotherapy):
Diffuse large B-cell, CD20-positive NHL:
Chronic lymphocytic leukemia (CLL):
Granulomatosis with polyangiitis (GPA [Wegener’s granulomatosis (WG)]) and microscopic polyangiitis (MPA):
Induction treatment of patients with active GPA/MPA: Methylprednisolone:
Rituximab:
Follow-up treatment (for patients with GPA/MPA who have achieved disease control with induction treatment): Methylprednisolone:
Therapeutic regimen with ibritumomab tiuxetan for treatment of NHL: Rituximab:
Rituxan and Truxima
Rheumatoid arthritis:
Rituxan
Component of the therapeutic regimen with ibritumomab tiuxetan (Zevalin) for treatment of NHL: Rituximab:
Pemphigus vulgaris:
PEDIATRIC DOSE
Rituxan
Induction treatment of pediatric patients with active GPA/MPA:
Follow-up treatment (for pediatric patients with GPA/MPA who have achieved disease control with induction treatment):
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ROMIDEPSIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: S
S
SARGRAMOSTIM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
SILDENAFIL **This drug is on the Black Box Warning list; however, a BBW is not provided in the parenteral prescribing info ...
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
SIPULEUCEL-T
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
SODIUM ACETATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
SODIUM BICARBONATE
USUAL DOSE
PEDIATRIC DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
SODIUM CHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
SODIUM FERRIC GLUCONATE COMPLEX
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
SOTALOL HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
SUGAMMADEX
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
SULFAMETHOXAZOLE AND TRIMETHOPRIM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: T
T
TACROLIMUS
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TAGRAXOFUSP-erzs
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TEDIZOLID PHOSPHATE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TELAVANCIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TEMOZOLOMIDE
USUAL DOSE
DOSE ADJUSTMENTS
Temozolomide Dose Modification Table for Refractory Anaplastic Astrocytoma:
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TEMSIROLIMUS
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TENECTEPLASE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TENIPOSIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
THIAMINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
SIDE EFFECTS
ANTIDOTE
THIOTEPA
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TIGECYCLINE FOR INJECTION
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TIROFIBAN HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TISAGENLECLEUCEL
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TOBRAMYCIN SULFATE
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TOCILIZUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TOPOTECAN HYDROCHLORIDE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TRANEXAMIC ACID
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TRASTUZUMAB  ■ TRASTUZUMAB-dkstaaPlease see p. x for more information on biosimilars.  ■ TRASTUZUMAB-dttba   ...
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: V
V
VALPROATE SODIUM
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
VANCOMYCIN HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
VASOPRESSIN INJECTION
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
VECURONIUM BROMIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
VEDOLIZUMAB
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
VERAPAMIL HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
VINBLASTINE SULFATE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
VINCRISTINE SULFATE  ■ VINCRISTINE SULFATE LIPOSOME INJECTION
USUAL DOSE
Conventional Vincristine
Marqibo (Liposomal Vincristine)
PEDIATRIC DOSE
Conventional Vincristine
Weight over 10 kg:
Weight 10 kg (22 lb) or less:
Marqibo (Liposomal Vincristine)
DOSE ADJUSTMENTS
Conventional Vincristine:
Marqibo (Liposomal Vincristine)
DILUTION
Conventional Vincristine:
Marqibo (Liposomal Vincristine):
Filters: Marqibo (liposomal vincristine):
Storage: Conventional vincristine:
Marqibo (liposomal vincristine):
COMPATIBILITY
Conventional Vincristine
Marqibo (Liposomal Vincristine)
RATE OF ADMINISTRATION
Conventional Vincristine
IV injection:
Infusion:
Marqibo (Liposomal Vincristine)
ACTIONS
Conventional Vincristine:
Marqibo (Liposomal Vincristine):
INDICATIONS AND USES
Conventional Vincristine:
Marqibo (Liposomal Vincristine):
Unlabeled uses: Conventional vincristine:
CONTRAINDICATIONS
PRECAUTIONS
Both Formulations:
Conventional Vincristine:
Marqibo (Liposomal Vincristine):
Monitor: Both Formulations:
Patient Education: Both formulations:
Maternal/Child: Both formulations:
Marqibo (liposomal vincristine):
Elderly: Both formulations:
DRUG/LAB INTERACTIONS
SIDE EFFECTS
Conventional Vincristine:
Marqibo (Liposomal Vincristine):
ANTIDOTE
VINORELBINE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
VON WILLEBRAND FACTOR/COAGULATION FACTOR VIII COMPLEX (HUMAN)
USUAL DOSE (International Units [IU])
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
VON WILLEBRAND FACTOR (RECOMBINANT)
USUAL DOSE (International Units [IU])
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
VORICONAZOLE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Generic drugs: Z
Z
ZIDOVUDINE
USUAL DOSE
PEDIATRIC DOSE
NEONATAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ZOLEDRONIC ACID
USUAL DOSE
Reclast and Zometa
Pretreatment:
Reclast
Treatment of Paget’s disease:
Calcium:
Vitamin D:
Treatment of osteoporosis in men and postmenopausal women and treatment and prevention of glucocorticoid-induced osteoporosis:
Prevention of osteoporosis in postmenopausal women:
Zometa
Hypercalcemia of malignancy (corrected serum calcium equal to or greater than 12 mg/dL [3 mmol/L]):
Multiple myeloma and metastatic bone lesions from solid tumors:
DOSE ADJUSTMENTS
Reclast and Zometa
Reclast
Zometa
Hypercalcemia of malignancy:
Multiple myeloma and metastatic bone lesions from solid tumors:
DILUTION
Reclast
Zometa
Single-use, ready-to-use-bottle:
Concentrate with 4 mg in 5 mL for single use:
Filters:
Storage: Reclast:
COMPATIBILITY
Reclast and Zometa
RATE OF ADMINISTRATION
Reclast
ACTIONS
Zoledronic Acid
Reclast
Zometa
INDICATIONS AND USES
Reclast
Limitation of use:
Zometa
Limitation of use:
CONTRAINDICATIONS
Reclast and Zometa
Reclast
PRECAUTIONS
Reclast and Zometa
Reclast
Zometa
Monitor: Reclast and Zometa:
Reclast:
Zometa:
Patient Education: Reclast and Zometa:
Reclast:
Zometa:
Maternal/Child:
Elderly:
DRUG/LAB INTERACTIONS
Reclast and Zometa
Zometa
SIDE EFFECTS
Reclast and Zometa
Reclast
Zometa
Post-Marketing:
Overdose:
ANTIDOTE
Reclast and Zometa
Zometa
APPENDIX A Recommendations for the safe use and handling of cytotoxic drugs
Appendix B FDA pregnancy categories
APPENDIX C U.s. department of health and human services, national institutes of health, national cancer institute common terminology criteria for adverse events (ctcae)
APPENDIX D Information for patients receiving immunosuppressive agents
APPENDIX E Recently approved drugs
AMISULPRIDE
BREXANOLONE
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CEFIDEROCOL
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CETIRIZINE HYDROCHLORIDE
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CRIZANLIZUMAB-tmca INJECTION
USUAL DOSE
PEDIATRIC DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
CYSTEINE HYDROCHLORIDE
USUAL DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ENFORTUMAB VEDOTIN-ejfv
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
FAM-TRASTUZUMAB DERUXTECAN-nxki
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
GOLODIRSEN INJECTION
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
IMIPENEM, CILASTATIN, AND RELEBACTAM
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
LEFAMULIN
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
MELOXICAM INJECTION
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
ONASEMNOGENE ABEPARVOVEC-xioi
PEDIATRIC DOSE
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
POLATUZUMAB VEDOTIN-piiq
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
TEPROTUMUMAB-trbw
USUAL DOSE
DOSE ADJUSTMENTS
DILUTION
COMPATIBILITY
RATE OF ADMINISTRATION
ACTIONS
INDICATIONS AND USES
CONTRAINDICATIONS
PRECAUTIONS
DRUG/LAB INTERACTIONS
SIDE EFFECTS
ANTIDOTE
Solution compatibility chart